J Smit A Gray L McFadyen K Zuma
10.1186/1472-6963-1-4
BMC Health Serv Res
2001;1:4.
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/11401729/
Contraceptive Agents, Female / economics Drug Costs / statistics & numerical data Health Expenditures / statistics & numerical data Medroxyprogesterone Acetate / economics Norethindrone / analogs & derivatives Norethindrone / economics
Contraceptive Agents, Female / economics Drug Costs / statistics & numerical data Health Expenditures / statistics & numerical data Medroxyprogesterone Acetate / economics Norethindrone / analogs & derivatives Norethindrone / economics Comparative Study Research Support, Non-U.S. Gov't Adolescent Adult Age Factors Choice Behavior Contraceptive Agents, Female / administration & dosage Contraceptive Agents, Female / adverse effects Contraceptive Agents, Female / supply & distribution Developing Countries / economics Drugs, Essential / economics Drugs, Essential / supply & distribution Female Fertility / drug effects Health Services Needs and Demand Humans Injections / economics Medroxyprogesterone Acetate / administration & dosage Medroxyprogesterone Acetate / adverse effects Medroxyprogesterone Acetate / supply & distribution Middle Aged Norethindrone / administration & dosage Norethindrone / adverse effects Norethindrone / supply & distribution Pharmacies / economics South Africa Treatment Outcome Contraceptive Agents, Female Drugs, Essential Medroxyprogesterone Acetate norethindrone enanthate Norethindrone
PMC32302
11401729
Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa
2001